Publication Name	World Journal of Diabetes
Manuscript ID	23192
Country	Japan

Received	2015-10-30 08:51
Peer-Review Started	2015-11-03 15:38
To Make the First Decision	2015-11-24 14:55
Return for Revision	2015-11-30 16:08
Revised	2015-12-13 10:36
Second Decision	2016-01-18 10:38
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2016-01-29 17:56
Articles in Press	2016-01-29 17:56
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2016-03-21 16:16
Publish the Manuscript Online	2016-03-23 21:36

ISSN	1948-9358 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Endocrinology & Metabolism
Manuscript Type	Review
Article Title	Low serum amylase and obesity, diabetes and metabolic syndrome: A novel interpretation
Manuscript Source	Invited Manuscript
All Author List	Kei Nakajima
Funding Agency and Grant Number
Corresponding Author	Kei Nakajima, MD, PhD, Department of Metabolism, Kuki General Hospital, 418-1 Kamihayami, Kuki, Saitama 346-8530, Japan. keinaka@josai.ac.jp
Key Words	Serum amylase; Salivary; Pancreas; Diabetes; Metabolic syndrome; Obesity; AMY1; AMY2; Insulin resistance
Core Tip	Low serum amylase was believed to occur in uncommon conditions such as type 1 diabetes, advanced chronic pancreatitis, and cystic fibrosis. However, in the last decade, low serum amylase has been observed in more common conditions related with insulin resistance than was previously believed. In this review, a novel interpretation for low serum, salivary, and pancreatic amylase is discussed, particularly in terms of the cardiometabolic conditions of obesity, diabetes, and metabolic syndrome.
Publish Date	2016-03-23 21:36
Citation	Nakajima K. Low serum amylase and obesity, diabetes and metabolic syndrome: A novel interpretation. World J Diabetes 2016; 7(6): 112-121
URL	http://www.wjgnet.com/1948-9358/full/v7/i6/112.htm
DOI	http://dx.doi.org/10.4239/wjd.v7.i6.112

Full Article (PDF)	WJD-7-112.pdf
Full Article (Word)	WJD-7-112.doc
Manuscript File	23192-Review.doc
Answering Reviewers	23192-Answering reviewers.pdf
Audio Core Tip	23192-Audio core tip .mp3
Conflict-of-Interest Disclosure Form	23192-Conflict-of-interest statement.pdf
Copyright License Agreement	23192-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate	23192-Language certificate.pdf
Peer-review Report	23192-Peer-review(s).pdf
Scientific Misconduct Check	23192-Scientific misconduct check.pdf
Scientific Editor Work List	23192-Scientific editor work list.pdf